Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 267-274

  Bissig, Heidi ^a   Richter, Jan ^a   Desper, Richard ^c   Meier, Verena ^a   Schraml, Peter ^a   Schäffer, Alejandro A ^b   Sauter, Guido ^a   Mihatsch, Michael J ^a   Moch, Holger ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE LOSS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; PRIORITY JOURNAL;

EID: 0033031878     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65120-6     Document Type: Article

References (50)

1. Robson C, Churchill B, Anderson W: The results of radical nephrectomy for renal cell carcinoma. J Urol 1969, 101:297-303
2. Weiss L, Harlos JP, Torhorst J, Gunthard B, Hartveit F, Svendsen E, Huang WL, Grundmann E, Eder M, Zwicknagl M: Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 1988, 114:605-612
3. Bennington J, Beckwith J: Tumors of the Kidney, Renal Pelvis and Ureter. Washington, DC. Armed Forces Institute of Pathology, 1975
4. Johnsen JA, Hellsten S: Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 1997, 157:450-453
5. Gastl G, Finstad CL, Guarini A, Bosl G, Gilboa E, Bander NH, Gansbacher B: Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 1992, 52:6229-6236
6. Trent JM, Stanisic T, Olson S: Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation, J Urol 1984, 131:146-151
7. Sato M, Hattori T, Nishimura T, Akimoto M: Characterization of primary and metastatic cell lines established from a patient with renal cell carcinoma. Nippon Hinyokika Gakkai Zasshi 1993, 84:650-655
8. Peier AM, Meloni AM, Sandberg AA, Leong SP, Carroll PR: Cytogenetic findings in a metastatic renal cell carcinoma. Cancer Genet Cytogenet 1995, 80:168-169
9. Gronwald J, Störkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997, 57:481-487
10. Moch H, Presti JC Jr, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996, 56:27-30
11. Kinoshita H, Yamada H, Ogawa O, Kakehi Y, Osaka M, Nakamura E, Mishina M, Habuchi T, Takahashi R, Sugiyama T, Yoshida O: Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma. Jpn J Cancer Res 1995, 86:795-799
12. Uhlman D, Nguyen P, Manivel J, Zhang G, Hagen K, Fraley E, Aeppä D, Niehans G: Epidermal growth factor receptor and transforming growth factor α expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Clin Cancer Res 1995, 1:913-920
13. Uhlman D, Nguyen P, Manivel J, Aeppli D, Resnick J, Fraley E. Zhang G, Niehans G: Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 1994, 86:21470-147524
14. Sauter G, Moch H, Gasser T, Mihatsch M, Waldman F: Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 1995, 21:40-46
15. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F: Chromosome analysis of 20 breast carcinomas: cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosomes & Cancer 1993, 6:51-57
16. Kallioniemi OP: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988, 9:164-169
17. Trent J, Yang JM, Emerson J, Dalton W, McGee D, Massey K, Thompson F, Villar H: Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease. Genes Chromosomes & Cancer 1993, 7:194-203
18. Waghorne C, Thomas M, Lagarde A: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res 1988, 48:6109-6114
19. Bell C, Frost P, Kerbel R: Cytogenetic heterogeneity of genetically marked and metastatically competent "dominant" tumor cell clones. Cancer Genet Cytogenet 1991, 54:153-161
20. Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi O, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997, 57:1597-1604
21. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821
22. Richter J, Jiang F, Görög J, Sartorius G, Egenter C, Gasser T, Moch H, Mihatsch M, Sauter G: Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997, 57:2860-2864
23. Jiang F, Richter J, Schraml P, Bubendorf L, Gasser T, Mihatsch M, Sauter G, Moch H: Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 1998, 153:1467-1473
24. Kallioniemi O, Kallioniemi A, Piper J, Isola J, Waldman F, Gray J, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes & Cancer 1994, 10:231-243
25. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994, 7:85-90
26. Li H, Schmidt L, Wei MH, Hustad T, Lerman MI, Zbar B, Tory K: Three tetrameric repeat polymorphisms on human chromosome 3: D3S1349; D3S1350; D3S1351. Hum Mol Genet 1993, 2:819
27. Crossey PA, Maher ER, Jones MH, Richards FM, Latif F, Phipps ME, Lush M, Foster K, Tory K, Green JS, Oostra B, Yates JRW, Linehan WM, Affara NA, Lerman M, Zbar B, Nakamura Y, Ferguson-Smith MA: Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Mol Genet 1993, 2:279-282
28. Zbar B, Brauch H, Talmadge C, Linehan M: Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987, 327:721-727
29. van den Berg A, Buys C: Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes & Cancer 1997, 19:59-76
30. Presti J, Rao H, Chen Q, Reuter V, Li F, Fair W, Jhanwar S: Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991, 51:1544-1552
31. Jiang F, Moch H, Richter J, Gasser T, Gschwind R, Egenter C, Bubendorf L, Sauter G. Mihatsch M: Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal cell carcinomas with sarcomatoid transformation. J Pathol 1998, 185:382-388
32. Isola J, Kallioniemi O, Chu L, Fuqua S, Hilsenbeck S, Osborne K, Waldman F: Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995, 147:905-911
33. Nowell PC: The clonal evolution of tumor cell populations. Science 1976, 194:23-28
34. Kushima M, Kushima R, Hattori T, Tomoyoshi T: Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells. Urol Res 1995, 23:381-386
35. Ljungberg B, Stenling R, Roos G: DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer 1985, 56:503-508
36. Baretton G, Kuhlmann B, Krech R, Lohrs U: Intratumoural heterogeneity of nuclear DNA-content and proliferation in clear cell type carcinomas of the kidney. Virchows Arch B Cell Pathol 1991, 61:57-63
37. Ljungberg B, Nordenson I, Roos G: Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma. Eur Urol 1991, 19:59-64
38. Nordenson I, Ljungberg B, Roos G: Chromosomes in renal carcinoma with reference to intratumor heterogeneity. Cancer Genet Cytogenet 1988, 32:35-41
39. Teixeira M, Bardi G, Andersen J, Heim S: Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 1996, 56:855-859
40. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994, 265:415-417
41. Kamb A, Liu Q, Harshman K, Tavtigian S, Cordon-Cardo C, Skolnick M: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994, 264:416-417
42. Cairns P, Tokino K, Eby Y, Sidransky D: Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 1995, 55:224-227
43. Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xiong Y, Beach DH, Yokota J, Harris CC: Mutations in the p16INK4/MTS1/ CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 1995, 55:1448-1451
44. Herrington CS, Leek RD, McGee JO: Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J Pathol 1995, 176:353-359
45. Weidner U, Peter S, Strohmeyer T, Hussnatter R, Ackermann R, Sies H: Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res 1990, 50:4504-4509
46. Joos S, Otano Joos MI, Ziegler S, Bruderlein S, du Manoir S, Bentz M, Moller P, Lichter P: Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996, 87:1571-1578
47. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T: Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998, 153:141-148
48. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y: DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998, 152:1107-1123
49. Gohji K, Nomi M, Hara I, Arakawa S, Kamidono S: Influence of cytokines and growth factors on matrix metalloproteinase-2 production and invasion of human renal cancer. Urol Res 1998, 26:33-37
50. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S: Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 1996, 56:2440-2445